Literature DB >> 33450849

High Monopolar Spindle 1 Is Associated with Short Survival of Cholangiocarcinoma Patients and Enhances the Progression Via AKT and STAT3 Signaling Pathways.

Piya Prajumwongs1,2, Ratthaphong Phumphu1,2, Orawan Waenphimai1,2, Worachart Lert-Itthiporn1,2, Kulthida Vaeteewoottacharn1,2, Sopit Wongkham1,2, Yaovalux Chamgramol2,3, Chawalit Pairojkul2,3, Kanlayanee Sawanyawisuth1,2.   

Abstract

Cholangiocarcinoma (CCA) is a malignancy of the bile duct epithelium. The major problems of this cancer are late diagnosis and a high rate of metastasis. CCA patients in advanced stages have poor survival and cannot be cured with surgery. Therefore, targeting molecules involved in the metastatic process may be an effective CCA treatment. Monopolar spindle 1 (MPS1) is a kinase protein that controls the spindle assemble checkpoint in mitosis. It is overexpressed in proliferating cells and various cancers. The functional roles of MPS1 in CCA progression have not been investigated. The aims of this study were to examine the roles and molecular mechanisms of MPS1 in CCA progression. Immunohistochemistry results showed that MPS1 was up-regulated in carcinogenesis of CCA in a hamster model, and positive expression of MPS1 in human CCA tissues was correlated to short survival of CCA patients (n = 185). Small interfering RNA (siRNA)-induced knockdown of MPS1 expression reduced cell proliferation via G2/M arrest, colony formation, migration, and invasion. Moreover, MPS1 controlled epithelial to mesenchymal transition (EMT)-mediated migration via AKT and STAT3 signaling transductions. MPS1 was also involved in MMPs-dependent invasion of CCA cell lines. The current research highlights for the first time that MPS1 has an essential role in promoting the progression of CCA via AKT and STAT3 signaling pathways and could be an attractive target for metastatic CCA treatment.

Entities:  

Keywords:  AKT; Cholangiocarcinoma; EMT; MMPs; MPS1; STAT3; invasion; migration

Year:  2021        PMID: 33450849      PMCID: PMC7828338          DOI: 10.3390/biomedicines9010068

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  39 in total

1.  Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.

Authors:  Jiamiao Zhang; Yan Jiang; Yu Zhao; Wanxue Wang; Yiran Xie; Huating Wang; Yihua Yang
Journal:  Tumour Biol       Date:  2017-07

Review 2.  The MPS1 family of protein kinases.

Authors:  Xuedong Liu; Mark Winey
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

3.  Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model.

Authors:  Suksanti Prakobwong; Puangrat Yongvanit; Yusuke Hiraku; Chawalit Pairojkul; Paiboon Sithithaworn; Porntip Pinlaor; Somchai Pinlaor
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

4.  Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.

Authors:  Linn Fagerberg; Björn M Hallström; Per Oksvold; Caroline Kampf; Dijana Djureinovic; Jacob Odeberg; Masato Habuka; Simin Tahmasebpoor; Angelika Danielsson; Karolina Edlund; Anna Asplund; Evelina Sjöstedt; Emma Lundberg; Cristina Al-Khalili Szigyarto; Marie Skogs; Jenny Ottosson Takanen; Holger Berling; Hanna Tegel; Jan Mulder; Peter Nilsson; Jochen M Schwenk; Cecilia Lindskog; Frida Danielsson; Adil Mardinoglu; Asa Sivertsson; Kalle von Feilitzen; Mattias Forsberg; Martin Zwahlen; IngMarie Olsson; Sanjay Navani; Mikael Huss; Jens Nielsen; Fredrik Ponten; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2013-12-05       Impact factor: 5.911

Review 5.  Liver fluke-associated cholangiocarcinoma.

Authors:  P Watanapa; W B Watanapa
Journal:  Br J Surg       Date:  2002-08       Impact factor: 6.939

6.  Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.

Authors:  Xiao-Dong Liang; Yue-Chu Dai; Zhao-Yun Li; Mei-Fu Gan; Shi-Rong Zhang; Hong-Sheng Lu; Xue-Quan Cao; Bei-jia Zheng; Ling-Fen Bao; Dan-Dan Wang; Li-Ming Zhang; Sheng-Lin Ma
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  MPS1 kinase as a potential therapeutic target in medulloblastoma.

Authors:  Irina Alimova; June Ng; Peter Harris; Diane Birks; Andrew Donson; Michael D Taylor; Nicholas K Foreman; Sujatha Venkataraman; Rajeev Vibhakar
Journal:  Oncol Rep       Date:  2016-09-12       Impact factor: 3.906

8.  TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.

Authors:  Qianqian Xu; Yali Xu; Bo Pan; Liangcai Wu; Xinyu Ren; Yidong Zhou; Feng Mao; Yan Lin; Jinghong Guan; Songjie Shen; Xiaohui Zhang; Changjun Wang; Ying Zhong; Liangrui Zhou; Zhiyong Liang; Haitao Zhao; Qiang Sun
Journal:  Oncotarget       Date:  2016-12-06

9.  Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer.

Authors:  Ying-Ming Tsai; Kuan-Li Wu; Yung-Yun Chang; Jen-Yu Hung; Wei-An Chang; Chao-Yuan Chang; Shu-Fang Jian; Pei-Hsun Tsai; Yung-Chi Huang; Inn-Wen Chong; Ya-Ling Hsu
Journal:  Int J Mol Sci       Date:  2020-02-28       Impact factor: 5.923

10.  Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells.

Authors:  Fei Zhang; Zhiyong Wang; Yanling Fan; Qiao Xu; Wei Ji; Ran Tian; Ruifang Niu
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.